Showing results (41-50 of 190) with videos related to
Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|June 1, 1997
Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faeciumR C Mercier, H H Houlihan, M J RybakAntimicrobial Agents and Chemotherapy|September 1, 1993
Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro modelB J McGrath, K C Lamp, M J RybakAntimicrobial Agents and Chemotherapy|May 17, 2001
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniaeE A Coyle, G W Kaatz, M J RybakPharmacotherapy|November 23, 2001
Rhodococcus equi pneumonia in a patient with human immunodeficiency virus: case report and reviewA L Kwa, V H Tam, M J RybakAntimicrobial Agents and Chemotherapy|June 1, 1991
Comparative effect of protein binding on the killing activities of teicoplanin and vancomycinE M Bailey, M J Rybak, G W KaatzClinical Pharmacokinetics|January 1, 1992
Ofloxacin clinical pharmacokineticsK C Lamp, E M Bailey, M J RybakThe Journal of Antimicrobial Chemotherapy|July 7, 2000
Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection modelH H Houlihan, D P Stokes, M J RybakPharmacotherapy|January 1, 1990
The triazole antifungal agents: a review of itraconazole and fluconazoleE M Bailey, D J Krakovsky, M J RybakAmerican Journal of Hospital Pharmacy|July 1, 1992
Pharmacy-based antimicrobial-monitoring serviceJ R Berman, F K Zaran, M J RybakPageof 19